Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide and Mesalazine in Patients with Active Sinistrial Colitis
DRKS00000308Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide, Salcrozine in autoimmune colitis, sponsored by AstraZeneca. Started Apr 2010; status: completed.
02
Drugs
budesonideSalcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on DRKS00000308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000308.